Pietro Bozzi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Adducts based on a bisphosphonate drug (sodium risedronate) and titanium dioxide (TiO(2)) particles have been developed and characterized in order to improve the bioavailability of orally administrated bisphosphonates. Nanocrystalline and colloidal TiO(2), both characterized by powder X-ray diffraction, were used to obtain the adducts 1 and 2, respectively.(More)
  • 1